Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Chronic Renal Failure

  Free Subscription


Articles published in J Clin Invest

Retrieve available abstracts of 11 articles:
HTML format



Single Articles


    July 2021
  1. ZHU K, Reiser J
    ALKBH1 reduces DNA N6-methyladenine to allow for vascular calcification in chronic kidney disease.
    J Clin Invest. 2021;131.
    PubMed     Abstract available


    June 2021
  2. SHIIZAKI K, Tsubouchi A, Miura Y, Seo K, et al
    Calcium phosphate microcrystals in the renal tubular fluid accelerate chronic kidney disease progression.
    J Clin Invest. 2021 Jun 29. pii: e145693. doi: 10.1172/JCI145693.
    PubMed     Abstract available


  3. SOLAGNA F, Tezze C, Lindenmeyer MT, Lu S, et al
    Pro-cachectic factors link experimental and human chronic kidney disease to skeletal muscle wasting programs.
    J Clin Invest. 2021;131.
    PubMed     Abstract available


    May 2021
  4. OUYANG L, Su X, Li W, Tang L, et al
    ALKBH1-demethylated DNA N6-methyladenine modification triggers vascular calcification via osteogenic reprogramming in chronic kidney disease.
    J Clin Invest. 2021 May 18. pii: 146985. doi: 10.1172/JCI146985.
    PubMed     Abstract available


    August 2020
  5. CHOU YH, Pan SY, Shao YH, Shih HM, et al
    Methylation in pericytes after acute injury promotes chronic kidney disease.
    J Clin Invest. 2020 Aug 4. pii: 135773. doi: 10.1172/JCI135773.
    PubMed     Abstract available


    June 2020
  6. ZHU X, Callahan MF, Gruber KA, Szumowski M, et al
    Melanocortin-4 receptor antagonist TCMCB07 ameliorates cancer- and chronic kidney disease-associated cachexia.
    J Clin Invest. 2020 Jun 16. pii: 138392. doi: 10.1172/JCI138392.
    PubMed     Abstract available


    May 2019
  7. GU X, Raman A, Susztak K
    Going from acute to chronic kidney injury with FoxO3.
    J Clin Invest. 2019;130.
    PubMed     Abstract available


    April 2019
  8. KOH KH, Cao Y, Mangos S, Tardi NJ, et al
    Nonimmune cell-derived ICOS ligand functions as a renoprotective alphavbeta3 integrin-selective antagonist.
    J Clin Invest. 2019;129:1713-1726.
    PubMed     Abstract available


    March 2019
  9. LI L, Kang H, Zhang Q, D'Agati VD, et al
    FoxO3 activation in hypoxic tubules prevents chronic kidney disease.
    J Clin Invest. 2019;130.
    PubMed     Abstract available


    April 2018
  10. TAMPE B, Tampe D, Nyamsuren G, Klopper F, et al
    Pharmacological induction of hypoxia-inducible transcription factor ARNT attenuates chronic kidney failure.
    J Clin Invest. 2018 Apr 17. pii: 89632. doi: 10.1172/JCI89632.
    PubMed     Abstract available


    June 2017
  11. COLVIN MM, Smith CA, Tullius SG, Goldstein DR, et al
    Aging and the immune response to organ transplantation.
    J Clin Invest. 2017;127:2523-2529.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Chronic Renal Failure is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: